至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Optimizing expression of the pregnancy malaria vaccine candidate, VAR2CSA in Pichia pastoris.

Malar. J.. 2009; 
AvrilMarion,HathawayMarianne J,CartwrightMegan M,GoseSeverin O,NarumDavid L,SmithJose
Products/Services Used Details Operation
Custom Vector Construction … across different VAR2CSA alleles. Methods. Design of DBL synthetic genes. Synthetic genes were constructed by (Genscript Corporation, Piscatway, NJ, USA) and codon optimized for P. pastoris expression. All N-glycosylation … Get A Quote

摘要

VAR2CSA is the main candidate for a vaccine against pregnancy-associated malaria, but vaccine development is complicated by the large size and complex disulfide bonding pattern of the protein. Recent X-ray crystallographic information suggests that domain boundaries of VAR2CSA Duffy binding-like (DBL) domains may be larger than previously predicted and include two additional cysteine residues. This study investigated whether longer constructs would improve VAR2CSA recombinant protein secretion from Pichia pastoris and if domain boundaries were applicable across different VAR2CSA alleles.

关键词